Emergent Biosolutions
EBS
EBS
167 hedge funds and large institutions have $818M invested in Emergent Biosolutions in 2014 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 61 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.79% more ownership
Funds ownership: 79.65% → 80.44% (+0.79%)
5% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 61
Holders
167
Holding in Top 10
2
Calls
$5K
Puts
–
Top Buyers
| 1 | +$7.54M | |
| 2 | +$5.67M | |
| 3 | +$4.07M | |
| 4 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
+$3.19M |
| 5 |
Axa
Paris,
France
|
+$3.19M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$4.55M | |
| 3 | -$4.34M | |
| 4 |
Goldman Sachs
New York
|
-$2.46M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$1.67M |